{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:18:32Z","timestamp":1762881512668,"version":"3.45.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10067-025-07760-x","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:00:16Z","timestamp":1760947216000},"page":"5143-5154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overlap of familial Mediterranean fever and APLAID treated with anakinra: a case-based review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-6268","authenticated-orcid":false,"given":"Gulsen","family":"Akoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-7456","authenticated-orcid":false,"given":"Ismail","family":"Yaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saliha","family":"Esenboga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-3417","authenticated-orcid":false,"given":"Sedat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6254-0369","authenticated-orcid":false,"given":"Deniz Dogan","family":"Mulazimoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-4627","authenticated-orcid":false,"given":"Deniz","family":"Cagdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"7760_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144. https:\/\/doi.org\/10.1016\/s0092-8674(00)80721-7","journal-title":"Cell"},{"key":"7760_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","volume":"366","author":"MJ Ombrello","year":"2012","unstructured":"Ombrello MJ, Remmers EF, Sun G et al (2012) Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 366:330\u2013338. https:\/\/doi.org\/10.1056\/NEJMoa1102140","journal-title":"N Engl J Med"},{"key":"7760_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Lee GS, Brady J et al (2012) A hypermorphic missense mutation in PLCG2, encoding phospholipase c\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am J Hum Genet 91:713\u2013720. https:\/\/doi.org\/10.1016\/j.ajhg.2012.08.006","journal-title":"Am J Hum Genet"},{"key":"7760_CR4","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.3389\/fimmu.2019.02448","volume":"10","author":"I Figueras-Nart","year":"2019","unstructured":"Figueras-Nart I, Mascar\u00f3 JM Jr, Solanich X, Hern\u00e1ndez-Rodr\u00edguez J (2019) Dermatologic and dermatopathologic features of monogenic autoinflammatory diseases. Front Immunol 10:2448. https:\/\/doi.org\/10.3389\/fimmu.2019.02448","journal-title":"Front Immunol"},{"key":"7760_CR5","doi-asserted-by":"publisher","first-page":"23083","DOI":"10.1074\/jbc.M109.019265","volume":"284","author":"KL Everett","year":"2009","unstructured":"Everett KL, Bunney TD, Yoon Y et al (2009) Characterization of phospholipase C gamma enzymes with gain-of-function mutations. J Biol Chem 284:23083\u201323093. https:\/\/doi.org\/10.1074\/jbc.M109.019265","journal-title":"J Biol Chem"},{"key":"7760_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.cellsig.2007.04.006","volume":"19","author":"G Drin","year":"2007","unstructured":"Drin G, Scarlata S (2007) Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding\u2013how many ways can you activate an enzyme? Cell Signal 19:1383\u20131392. https:\/\/doi.org\/10.1016\/j.cellsig.2007.04.006","journal-title":"Cell Signal"},{"key":"7760_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s1074-7613(00)00005-4","volume":"13","author":"D Wang","year":"2000","unstructured":"Wang D, Feng J, Wen R et al (2000) Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25\u201335. https:\/\/doi.org\/10.1016\/s1074-7613(00)00005-4","journal-title":"Immunity"},{"key":"7760_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/art.38961","volume":"67","author":"JJ Chae","year":"2015","unstructured":"Chae JJ, Park YH, Park C et al (2015) Connecting two pathways through Ca 2+ signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation. Arthritis Rheumatol 67:563\u2013567. https:\/\/doi.org\/10.1002\/art.38961","journal-title":"Arthritis Rheumatol"},{"key":"7760_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667430","volume":"12","author":"N Wu","year":"2021","unstructured":"Wu N, Zhang B, Wang T, Shen M, Zeng X (2021) Case report: a rare case of autoinflammatory phospholipase C\u03b32 (PLC\u03b32)-associated antibody deficiency and immune dysregulation complicated with gangrenous pyoderma and literature review. Front Immunol 12:667430. https:\/\/doi.org\/10.3389\/fimmu.2021.667430","journal-title":"Front Immunol"},{"key":"7760_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41590-023-01473-6","volume":"24","author":"E Mulazzani","year":"2023","unstructured":"Mulazzani E, Kong K, Ar\u00f3stegui JI et al (2023) G-CSF drives autoinflammation in APLAID. Nat Immunol 24:814\u2013826. https:\/\/doi.org\/10.1038\/s41590-023-01473-6","journal-title":"Nat Immunol"},{"key":"7760_CR11","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3389\/fimmu.2018.02863","volume":"9","author":"JF Neves","year":"2018","unstructured":"Neves JF, Doffinger R, Barcena-Morales G et al (2018) Novel PLCG2 mutation in a patient with APLAID and cutis laxa. Front Immunol 9:2863. https:\/\/doi.org\/10.3389\/fimmu.2018.02863","journal-title":"Front Immunol"},{"key":"7760_CR12","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1111\/jdv.15918","volume":"33","author":"E Mor\u00e1n-Villase\u00f1or","year":"2019","unstructured":"Mor\u00e1n-Villase\u00f1or E, Saez-de-Ocariz M, Torrelo A et al (2019) Expanding the clinical features of autoinflammation and phospholipase C\u03b32-associated antibody deficiency and immune dysregulation by description of a novel patient. J Eur Acad Dermatol Venereol 33:2334\u20132339. https:\/\/doi.org\/10.1111\/jdv.15918","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7760_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10875-019-00731-3","volume":"40","author":"T Novice","year":"2020","unstructured":"Novice T, Kariminia A, Del Bel KL et al (2020) A germline mutation in the C2 domain of PLC\u03b32 associated with gain-of-function expands the phenotype for PLCG2-related diseases. J Clin Immunol 40:267\u2013276. https:\/\/doi.org\/10.1007\/s10875-019-00731-3","journal-title":"J Clin Immunol"},{"key":"7760_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2020.01.008","volume":"221","author":"A Khabbazi","year":"2020","unstructured":"Khabbazi A, Rahbar Kafshboran H, Nasiri Aghdam M et al (2020) A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran. Immunol Lett 221:27\u201332. https:\/\/doi.org\/10.1016\/j.imlet.2020.01.008","journal-title":"Immunol Lett"},{"key":"7760_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","volume":"40","author":"A Mart\u00edn-Nalda","year":"2020","unstructured":"Mart\u00edn-Nalda A, Fortuny C, Rey L et al (2020) Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic PLCG2 mutations. J Clin Immunol 40:987\u20131000. https:\/\/doi.org\/10.1007\/s10875-020-00794-7","journal-title":"J Clin Immunol"},{"key":"7760_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104387","volume":"65","author":"HS Park","year":"2022","unstructured":"Park HS, Oh A, Keum CW et al (2022) A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B-cell lymphopenia. Eur J Med Genet 65:104387. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104387","journal-title":"Eur J Med Genet"},{"key":"7760_CR17","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1093\/rheumatology\/kead193","volume":"62","author":"T Itakura","year":"2023","unstructured":"Itakura T, Sasaki H, Hosoya T et al (2023) A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia. Rheumatology (Oxford) 62:e319\u2013e321. https:\/\/doi.org\/10.1093\/rheumatology\/kead193","journal-title":"Rheumatology (Oxford)"},{"key":"7760_CR18","doi-asserted-by":"publisher","first-page":"1014150","DOI":"10.3389\/fimmu.2023.1014150","volume":"14","author":"Q Peng","year":"2023","unstructured":"Peng Q, Luo D, Yang Y et al (2023) Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2. Front Immunol 14:1014150. https:\/\/doi.org\/10.3389\/fimmu.2023.1014150","journal-title":"Front Immunol"},{"key":"7760_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12026-024-09455-y","volume":"72","author":"T Wang","year":"2024","unstructured":"Wang T, Wang X, Teng Y et al (2024) Aplaid complicated with arrhythmogenic dilated cardiomyopathy caused by a novel PLCG2 variant. Immunol Res 72:512\u2013519. https:\/\/doi.org\/10.1007\/s12026-024-09455-y","journal-title":"Immunol Res"},{"key":"7760_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaci.2023.08.036","volume":"153","author":"K Baysac","year":"2024","unstructured":"Baysac K, Sun G, Nakano H et al (2024) PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol 153:230\u2013242. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.036","journal-title":"J Allergy Clin Immunol"},{"key":"7760_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/art.42948","author":"Z Yang","year":"2024","unstructured":"Yang Z, Tao P, Han X et al (2024) Characterization of a novel pathogenic PLCG2 variant leading to APLAID syndrome responsive to a TNF inhibitor. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42948","journal-title":"Arthritis Rheumatol"},{"key":"7760_CR22","doi-asserted-by":"publisher","first-page":"1556372","DOI":"10.3389\/fimmu.2025.1556372","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, Zhang J, Shen M (2025) Case report: De novo in-frame deletion in PLCG2 gene: a case report of B-cell lymphopenia, pulmonary bullae, and cutis laxa. Front Immunol 16:1556372. https:\/\/doi.org\/10.3389\/fimmu.2025.1556372","journal-title":"Front Immunol"},{"key":"7760_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A et al (2022) Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies expert committee. J Clin Immunol 42:1473\u20131507. https:\/\/doi.org\/10.1007\/s10875-022-01289-3","journal-title":"J Clin Immunol"},{"key":"7760_CR24","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41467-017-01388-5","volume":"8","author":"M Yu","year":"2017","unstructured":"Yu M, Chen Y, Zeng H et al (2017) PLC\u03b3-dependent mTOR signalling controls IL-7-mediated early B cell development. Nat Commun 8:1457. https:\/\/doi.org\/10.1038\/s41467-017-01388-5","journal-title":"Nat Commun"},{"key":"7760_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/rheumatology\/keae338","volume":"64","author":"P Mertz","year":"2025","unstructured":"Mertz P, Hentgen V, Georgin-Lavialle S (2025) Could tocilizumab be used in familial Mediterranean fever? A systematic review. Rheumatology (Oxford) 64:12\u201321. https:\/\/doi.org\/10.1093\/rheumatology\/keae338","journal-title":"Rheumatology (Oxford)"},{"key":"7760_CR26","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1093\/rheumatology\/keaa005","volume":"59","author":"M Kiyota","year":"2020","unstructured":"Kiyota M, Oya M, Ayano M et al (2020) First case of pyrin-associated autoinflammation with neutrophilic dermatosis complicated by amyloidosis. Rheumatology (Oxford) 59:e41\u2013e43. https:\/\/doi.org\/10.1093\/rheumatology\/keaa005","journal-title":"Rheumatology (Oxford)"},{"key":"7760_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41423-020-00608-1","volume":"18","author":"J Florentin","year":"2021","unstructured":"Florentin J, Zhao J, Tai YY et al (2021) Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension. Cell Mol Immunol 18:374\u2013384. https:\/\/doi.org\/10.1038\/s41423-020-00608-1","journal-title":"Cell Mol Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:15:29Z","timestamp":1762881329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7760"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07760-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient signed written informed consent for the review and publication of his medical files and clinical photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}